DIAMEDICA THERAPEUTICS INC. (DMAC) Operating cash flow 2017–2025
DIAMEDICA THERAPEUTICS INC. (DMAC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$29.1MFY2025 · since FY2017: -$3.9M → -$29.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.1M | -31.6% |
| FY2024 | -$22.1M | -17.9% |
| FY2023 | -$18.7M | -62.7% |
| FY2022 | -$11.5M | +6.0% |
| FY2021 | -$12.3M | -33.4% |
| FY2020 | -$9.2M | -0.9% |
| FY2019 | -$9.1M | -59.8% |
| FY2018 | -$5.7M | -46.1% |
| FY2017 | -$3.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice